세계의 ECG 케이블 및 리드선 시장 : 유형별, 재질별, 사용법별, 최종 사용자별, 지역별 예측(-2030년)

The global ECG cable & lead wire market is projected to reach USD 3.76 billion by 2030 from USD 2.70 billion in 2025, growing at a CAGR of 6.8% during the forecast period.

The demand for ECG cables & lead wires is witnessing steady growth, driven by the rising global burden of cardiovascular diseases. Increasing adoption of remote and real-time cardiac monitoring, along with the shift toward home-based care, is boosting product utilization.

Hospitals and diagnostic centers prioritize high-quality, durable, and biocompatible cables to ensure accurate readings and patient safety. Technological innovations such as wireless ECG systems, disposable lead wires for infection control, and compatibility with multi-parameter monitoring devices further enhance market adoption. Moreover, expanding healthcare infrastructure in emerging economies and favorable government initiatives supporting preventive healthcare are expected to sustain strong market growth in the coming years.

"By type, the ECG lead wire is projected to account for the largest share."

The market is segmented into ECG lead wires and ECG cables based on type. In 2024, the ECG lead wire segment held the largest market share, driven by the rising geriatric population and the growing prevalence of cardiovascular diseases (CVDs). Technological advancements, along with the implementation of enhanced cardiac care practices in developed countries, are further propelling market growth. The increasing demand for accurate, durable, and patient-friendly monitoring solutions also contributes to the dominance of the ECG lead wire segment in the global market.

"By usability, the disposable cable & lead wire segment is estimated to register the highest growth rate."

Based on usability, the market is segmented into reusable cable and lead wire and disposable cable and lead wire. In 2024, the disposable cable and lead wire segment is projected to register the highest growth rate due to the rising focus on infection prevention, increasing adoption of single-use medical accessories, and growing awareness of patient safety and hygiene. Additionally, the expanding use of disposable products in hospitals, clinics, and ambulatory care settings, driven by regulatory guidelines and advancements in cost-effective materials, further supports the segment's rapid growth.

In 2024, North America accounted for the largest market share of the ECG cable & lead wire market, by region.

The ECG cable & lead wire market is segmented into North America, Europe, Latin America, the Asia Pacific, and the Middle East & Africa. North America leads the global market; this dominance is attributed to the high prevalence of cardiovascular diseases, well-established healthcare infrastructure, and rapid adoption of advanced monitoring technologies. Additionally, strong presence of key market players, increased healthcare spending, and growing demand for continuous patient monitoring in hospitals and home healthcare settings further contribute to the region's leading market position.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1 - 40%, Tier 2 - 35%, and Tier 3 - 25%
• By Designation: Directors - 23%, Managers - 30%, and Others - 47%
• By Region: North America - 25%, Europe - 35%, the Asia Pacific - 20%, Latin America - 13%, and the Middle East & Africa - 7%

The prominent players in the ECG cable & lead wire market are Cardinal Health (US), Solventum (US), GE Healthcare (US), Koninklijke Philips N.V. (Netherlands), Boston Scientific Corporation (US), CONMED Corporation (US), OSI Systems, Inc. (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Baxter (US), Siemens Healthineers AG (Germany), Dragerwerk Ag & Co. KGaA (Germany), Schiller AG (US), Curbell Medical Products, Inc. (US), Shanghai Berry Electronic Tech Co., Ltd (China), Unimed Medical Supplies Inc. (China), Amydi-med Electronic Technology Co., Ltd. (China), Med-Linket Corp (China), Sorimex (Poland), Nuova Gmbh (Germany), LUMED Srl (Italy), and Shenzhen UpnMed Equipment Co., Ltd.(China), among others.

Research Coverage

This report studies the ECG cable & lead wire market based on device type, service type, service provider, contract type, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the following strategies to strengthen their market presence.

This report provides insights into the following pointers:

• Analysis of key drivers (global rising geriatric population, increasing prevalence of cardiovascular diseases, growing adoption of disposable/single-patient lead wires driven by infection-control priorities), restraints (high cost of disposable cable and lead wires), opportunities (untapped growth potential in emerging markets, advanced and high-performance features in ECG cables and lead wires), and challenges (compatibility issues with ECG cable & lead wire) influencing the growth of ECG cable & lead wire market
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the ECG cable & lead wire market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product developments in the ECG cable & lead wire market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the ECG cable & lead wire market
• Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Primary sources
    • 2.1.2.2 Key industry insights
    • 2.1.2.3 Breakdown of primaries
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 REVENUE SHARE ANALYSIS (BOTTOM-UP APPROACH)
  • 2.2.2 COMPANY INVESTOR PRESENTATIONS AND PRIMARY INTERVIEWS
  • 2.2.3 TOP-DOWN APPROACH
  • 2.2.4 BOTTOM-UP APPROACH
  • 2.2.5 PRIMARY INTERVIEWS
  • 2.2.6 VOLUME DATA ANALYSIS
• 2.3 GROWTH FORECAST MODEL
• 2.4 DATA TRIANGULATION
• 2.5 RESEARCH ASSUMPTIONS
• 2.6 RESEARCH LIMITATIONS
• 2.7 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ECG CABLE & LEAD WIRE MARKET OVERVIEW
• 4.2 ASIA PACIFIC: ECG CABLE & LEAD WIRE MARKET, BY COUNTRY AND END USER
• 4.3 GEOGRAPHIC SNAPSHOT OF ECG CABLE & LEAD WIRE MARKET

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rising geriatric population
    • 5.2.1.2 Increasing prevalence of cardiovascular diseases
    • 5.2.1.3 Growing emphasis on infection control and increasing prevalence of cardiovascular diseases
    • 5.2.1.4 Shift toward remote and home-based care
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High cost of disposable cables and lead wires
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Untapped growth potential in emerging markets
    • 5.2.3.2 Increasing adoption of premium features
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Compatibility issues
• 5.3 UNMET NEEDS AND WHITE SPACES
  • 5.3.1 UNMET NEEDS
  • 5.3.2 WHITE SPACE OPPORTUNITIES
• 5.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
  • 5.4.1 INTERCONNECTED MARKETS
  • 5.4.2 CROSS-SECTOR OPPORTUNITIES
• 5.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
  • 5.5.1 UNMET NEEDS IN ECG CABLE & LEAD WIRE MARKET

6 STRATEGIC DISRUPTIONS THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTIONS

• 6.1 TECHNOLOGY ANALYSIS
  • 6.1.1 KEY EMERGING TECHNOLOGIES
    • 6.1.1.1 Signal processing & noise reduction
    • 6.1.1.2 Advanced shielding technologies
  • 6.1.2 COMPLEMENTARY TECHNOLOGIES
    • 6.1.2.1 Wearable technology integration
    • 6.1.2.2 Disposable systems with antimicrobial and biocompatible materials
  • 6.1.3 ADJACENT TECHNOLOGIES
    • 6.1.3.1 Electrode-free ECG monitoring
    • 6.1.3.2 Smart textile ECG systems
• 6.2 TECHNOLOGY/PRODUCT ROADMAP
  • 6.2.1 NEAR TERM (2025-2027)
  • 6.2.2 MID TERM (2028-2030)
  • 6.2.3 LONG TERM (2030+)
• 6.3 PATENT ANALYSIS
  • 6.3.1 JURISDICTION AND TOP APPLICANT ANALYSIS
  • 6.3.2 LIST OF PATENTS
• 6.4 FUTURE APPLICATIONS
  • 6.4.1 RADIOLUCENT AND IMAGING-COMPATIBLE LEAD WIRES
  • 6.4.2 LOW-NOISE, HIGH-FIDELITY, AND DURABLE CONDUCTOR TECHNOLOGIES
  • 6.4.3 INTEROPERABILITY AND UNIVERSAL CONNECTOR STANDARDIZATION
  • 6.4.4 SEAMLESS INTEGRATION WITH WEARABLES AND IOT HEALTH PLATFORMS
• 6.5 IMPACT OF AI/GEN AI ON ECG CABLE & LEAD WIRE MARKET
  • 6.5.1 INTRODUCTION
  • 6.5.2 MARKET POTENTIAL OF AI IN ECG CABLE & LEAD WIRE MARKET
  • 6.5.3 AI USE CASES
  • 6.5.4 KEY COMPANIES IMPLEMENTING AI

7 INDUSTRY TRENDS

• 7.1 PORTER'S FIVE FORCES ANALYSIS
  • 7.1.1 THREAT OF NEW ENTRANTS
  • 7.1.2 THREAT OF SUBSTITUTES
  • 7.1.3 BARGAINING POWER OF SUPPLIERS
  • 7.1.4 BARGAINING POWER OF BUYERS
  • 7.1.5 INTENSITY OF COMPETITIVE RIVALRY
• 7.2 MACROECONOMIC INDICATORS
  • 7.2.1 INTRODUCTION
  • 7.2.2 GDP TRENDS AND FORECAST
  • 7.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY
  • 7.2.4 TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY
• 7.3 SUPPLY CHAIN ANALYSIS
• 7.4 VALUE CHAIN ANALYSIS
• 7.5 ECOSYSTEM ANALYSIS
• 7.6 PRICING ANALYSIS
  • 7.6.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
  • 7.6.2 AVERAGE SELLING PRICE TREND, BY REGION
• 7.7 TRADE ANALYSIS
  • 7.7.1 IMPORT DATA FOR HS CODE 901890
  • 7.7.2 EXPORT DATA FOR HS CODE 901890
• 7.8 REIMBURSEMENT SCENARIO
• 7.9 KEY CONFERENCES AND EVENTS, 2025-2026
• 7.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 7.11 INVESTMENT AND FUNDING SCENARIO
• 7.12 CASE STUDY ANALYSIS
  • 7.12.1 CASE STUDY 1: CONTINUOUS AND STABLE MONITORING IMPLANTATION WITH SINGLE-USE ECG LEAD WIRES
  • 7.12.2 CASE STUDY 2: INFECTION PREVENTION THROUGH SINGLE-USE ECG LEAD WIRES
  • 7.12.3 CASE STUDY 3: REDUCED ALARM FATIGUE AND INFECTIONS USING SINGLE-USE ECG LEAD WIRES
• 7.13 IMPACT OF 2025 US TARIFF
  • 7.13.1 INTRODUCTION
  • 7.13.2 KEY TARIFF RATES
  • 7.13.3 PRICE IMPACT ANALYSIS
  • 7.13.4 IMPACT ON COUNTRY/REGION
  • 7.13.5 IMPACT ON END-USE SEGMENTS

8 SUSTAINABILITY AND REGULATORY LANDSCAPE

• 8.1 REGULATORY LANDSCAPE
  • 8.1.1 REGULATORY FRAMEWORK
    • 8.1.1.1 North America
    • 8.1.1.2 Europe
    • 8.1.1.3 Asia Pacific
    • 8.1.1.4 Latin America
    • 8.1.1.5 Middle East & Africa
  • 8.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 8.1.3 INDUSTRY STANDARDS
• 8.2 SUSTAINABILITY INITIATIVES
  • 8.2.1 RECYCLED AND ECO-FRIENDLY MATERIALS FOR ECG CABLE & LEAD WIRE
  • 8.2.2 SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES
  • 8.2.3 CERTIFICATIONS, LABELING, ECO-STANDARDS

9 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

• 9.1 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 9.1.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 9.1.2 BUYING CRITERIA
• 9.2 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
  • 9.2.1 DECISION-MAKING PROCESS
  • 9.2.2 ADOPTION BARRIERS & INTERNAL CHALLENGES
  • 9.2.3 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
  • 9.2.4 MARKET PROFITABILITY

10 ECG CABLE & LEAD WIRE MARKET, BY TYPE

• 10.1 INTRODUCTION
• 10.2 ECG LEAD WIRES
  • 10.2.1 12-LEAD ECG LEAD WIRES
    • 10.2.1.1 Increasing need for cardiac monitoring to expedite growth
  • 10.2.2 5-LEAD ECG LEAD WIRES
    • 10.2.2.1 Wide use of 5-lead wires in intensive care units, operating rooms, and step-down units to aid growth
  • 10.2.3 3-LEAD ECG LEAD WIRES
    • 10.2.3.1 Cost-effectiveness and lower technical complexity to sustain growth
  • 10.2.4 6-LEAD ECG LEAD WIRES
    • 10.2.4.1 Growing adoption of 6-lead ECG wires in ambulatory and remote diagnostics to drive market
  • 10.2.5 SINGLE-LEAD ECG LEAD WIRES
    • 10.2.5.1 Growth in wearables and home care settings to drive market
  • 10.2.6 OTHER ECG LEAD WIRES
• 10.3 ECG CABLES
  • 10.3.1 INCREASING HOSPITAL INVESTMENTS IN ADVANCED CARDIAC MONITORING SYSTEMS TO PROMOTE GROWTH

11 ECG CABLE & LEAD WIRE MARKET, BY MATERIAL

• 11.1 INTRODUCTION
• 11.2 THERMOPLASTIC POLYURETHANE
  • 11.2.1 HIGHER FLEXIBILITY, ABRASION RESISTANCE, AND BIOCOMPATIBILITY TO SPUR GROWTH
• 11.3 THERMOPLASTIC ELASTOMER
  • 11.3.1 GROWING TREND TOWARD SINGLE-PATIENT-USE CONSUMABLES AND INFECTION CONTROL TO FUEL MARKET
• 11.4 OTHER MATERIALS

12 ECG CABLE & LEAD WIRE MARKET, BY USABILITY

• 12.1 INTRODUCTION
• 12.2 REUSABLE ECG CABLES & LEAD WIRES
  • 12.2.1 COST-EFFECTIVENESS AND DURABILITY TO ENCOURAGE GROWTH
• 12.3 DISPOSABLE ECG CABLES & LEAD WIRES
  • 12.3.1 INCREASING FOCUS ON ENHANCED PATIENT SAFETY AND REDUCED RISK OF CROSS-CONTAMINATION TO BOOST MARKET

13 ECG CABLE & LEAD WIRE MARKET, BY END USER

• 13.1 INTRODUCTION
• 13.2 HOSPITALS
  • 13.2.1 GROWING PATIENT VOLUME TO DRIVE MARKET
• 13.3 PRIMARY CARE CENTERS
  • 13.3.1 INCREASING EMPHASIS ON PREVENTIVE CARDIOLOGY AND POINT-OF-CARE TESTING TO SUPPORT GROWTH
• 13.4 CARDIAC CENTERS
  • 13.4.1 RISING CARDIAC PROCEDURES GLOBALLY TO AID GROWTH
• 13.5 AMBULATORY SURGICAL CENTERS
  • 13.5.1 SHORT PATIENT TURNOVER AND STRINGENT INFECTION CONTROL REQUIREMENTS TO FACILITATE GROWTH
• 13.6 HOME CARE SETTINGS
  • 13.6.1 RISE IN AGING POPULATIONS, SELF-MONITORING DEVICES, AND POST-DISCHARGE CARE PROGRAMS TO ACCELERATE GROWTH
• 13.7 OTHER END USERS

14 ECG CABLE & LEAD WIRE MARKET, BY REGION

• 14.1 INTRODUCTION
• 14.2 NORTH AMERICA
  • 14.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 14.2.2 US
    • 14.2.2.1 Growing prevalence of chronic diseases and expanding elderly population to drive market
  • 14.2.3 CANADA
    • 14.2.3.1 Rising geriatric patient pool to foster growth
• 14.3 EUROPE
  • 14.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 14.3.2 GERMANY
    • 14.3.2.1 Increasing healthcare expenditure to expedite growth
  • 14.3.3 UK
    • 14.3.3.1 Rising adoption of advanced healthcare systems to support growth
  • 14.3.4 FRANCE
    • 14.3.4.1 Rising digital expansion to propel market
  • 14.3.5 ITALY
    • 14.3.5.1 Growing prevalence of age-related cardiovascular conditions to boost market
  • 14.3.6 SPAIN
    • 14.3.6.1 Ongoing healthcare modernization and focus on early detection to aid growth
  • 14.3.7 REST OF EUROPE
• 14.4 ASIA PACIFIC
  • 14.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 14.4.2 CHINA
    • 14.4.2.1 Favorable government support and rising disease burden to drive market
  • 14.4.3 JAPAN
    • 14.4.3.1 High healthcare expenditure, favorable reimbursement, and insurance coverage to aid growth
  • 14.4.4 INDIA
    • 14.4.4.1 Increasing burden of cardiovascular diseases and strong government support to propel market
  • 14.4.5 SOUTH KOREA
    • 14.4.5.1 Rising ageing population to bolster growth
  • 14.4.6 AUSTRALIA
    • 14.4.6.1 Rising hospitalization rates to contribute to growth
  • 14.4.7 REST OF ASIA PACIFIC
• 14.5 LATIN AMERICA
  • 14.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 14.5.2 BRAZIL
    • 14.5.2.1 Expanding healthcare coverage and demand for essential diagnostic tools to aid growth
  • 14.5.3 MEXICO
    • 14.5.3.1 Rising cardiovascular risk and upgrades to diagnostic infrastructure to drive market
  • 14.5.4 REST OF LATIN AMERICA
• 14.6 MIDDLE EAST & AFRICA
  • 14.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 14.6.2 GCC COUNTRIES
    • 14.6.2.1 Kingdom of Saudi Arabia (KSA)
      • 14.6.2.1.1 Growing disease burden to boost market
    • 14.6.2.2 United Arab Emirates (UAE)
      • 14.6.2.2.1 Need for advanced cardiac monitoring and preventive solutions to promote growth
    • 14.6.2.3 Rest of GCC countries
  • 14.6.3 REST OF MIDDLE EAST & AFRICA

15 COMPETITIVE LANDSCAPE

• 15.1 OVERVIEW
• 15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 15.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS
• 15.3 REVENUE ANALYSIS, 2022-2024
• 15.4 MARKET SHARE ANALYSIS, 2024
• 15.5 COMPANY VALUATION AND FINANCIAL METRICS
• 15.6 BRAND COMPARISON
• 15.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 15.7.1 STARS
  • 15.7.2 EMERGING LEADERS
  • 15.7.3 PERVASIVE PLAYERS
  • 15.7.4 PARTICIPANTS
  • 15.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 15.7.5.1 Company footprint
    • 15.7.5.2 Region footprint
    • 15.7.5.3 Type footprint
    • 15.7.5.4 Lead wire type footprint
    • 15.7.5.5 Usability footprint
• 15.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 15.8.1 PROGRESSIVE COMPANIES
  • 15.8.2 RESPONSIVE COMPANIES
  • 15.8.3 DYNAMIC COMPANIES
  • 15.8.4 STARTING BLOCKS
  • 15.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 15.8.5.1 Detailed list of key startups/SMEs
    • 15.8.5.2 Competitive benchmarking of key startups/SMEs
• 15.9 COMPETITIVE SCENARIO
  • 15.9.1 PRODUCT LAUNCHES AND APPROVALS
  • 15.9.2 DEALS
  • 15.9.3 EXPANSIONS
  • 15.9.4 OTHER DEVELOPMENTS

16 COMPANY PROFILES

• 16.1 KEY PLAYERS
  • 16.1.1 CARDINAL HEALTH
    • 16.1.1.1 Business overview
    • 16.1.1.2 Products offered
    • 16.1.1.3 Recent developments
      • 16.1.1.3.1 Product launches and approvals
      • 16.1.1.3.2 Expansions
    • 16.1.1.4 MnM view
      • 16.1.1.4.1 Right to win
      • 16.1.1.4.2 Strategic choices
      • 16.1.1.4.3 Weaknesses and competitive threats
  • 16.1.2 KONINKLIJKE PHILIPS N.V.
    • 16.1.2.1 Business overview
    • 16.1.2.2 Products offered
    • 16.1.2.3 Recent developments
      • 16.1.2.3.1 Product launches and approvals
      • 16.1.2.3.2 Deals
    • 16.1.2.4 MnM view
      • 16.1.2.4.1 Right to win
      • 16.1.2.4.2 Strategic choices
      • 16.1.2.4.3 Weaknesses and competitive threats
  • 16.1.3 SOLVENTUM
    • 16.1.3.1 Business overview
    • 16.1.3.2 Products offered
    • 16.1.3.3 Recent developments
      • 16.1.3.3.1 Deals
    • 16.1.3.4 MnM view
      • 16.1.3.4.1 Right to win
      • 16.1.3.4.2 Strategic choices
      • 16.1.3.4.3 Weaknesses and competitive threats
  • 16.1.4 GE HEALTHCARE
    • 16.1.4.1 Business overview
    • 16.1.4.2 Products offered
    • 16.1.4.3 Recent developments
      • 16.1.4.3.1 Deals
    • 16.1.4.4 MnM view
      • 16.1.4.4.1 Right to win
      • 16.1.4.4.2 Strategic choices
      • 16.1.4.4.3 Weaknesses and competitive threats
  • 16.1.5 BOSTON SCIENTIFIC CORPORATION
    • 16.1.5.1 Business overview
    • 16.1.5.2 Products offered
    • 16.1.5.3 Recent developments
      • 16.1.5.3.1 Deals
    • 16.1.5.4 MnM view
      • 16.1.5.4.1 Key strengths
      • 16.1.5.4.2 Strategic choices
      • 16.1.5.4.3 Weaknesses and competitive threats
  • 16.1.6 CONMED CORPORATION
    • 16.1.6.1 Business overview
    • 16.1.6.2 Products offered
  • 16.1.7 OSI SYSTEMS, INC.
    • 16.1.7.1 Business overview
    • 16.1.7.2 Products offered
    • 16.1.7.3 Recent developments
      • 16.1.7.3.1 Expansions
      • 16.1.7.3.2 Other developments
  • 16.1.8 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    • 16.1.8.1 Business overview
    • 16.1.8.2 Products offered
    • 16.1.8.3 Recent developments
      • 16.1.8.3.1 Other developments
  • 16.1.9 BAXTER
    • 16.1.9.1 Business overview
    • 16.1.9.2 Products offered
  • 16.1.10 DRAGERWERK AG & CO. KGAA
    • 16.1.10.1 Business overview
    • 16.1.10.2 Products offered
  • 16.1.11 SIEMENS HEALTHINEERS AG
    • 16.1.11.1 Business overview
    • 16.1.11.2 Products offered
• 16.2 OTHER PLAYERS
  • 16.2.1 CURBELL MEDICAL PRODUCTS, INC.
  • 16.2.2 SCHILLER AG
  • 16.2.3 SHANGHAI BERRY ELECTRONIC TECH CO., LTD.
  • 16.2.4 UNIMED MEDICAL
  • 16.2.5 AMYDI-MED
  • 16.2.6 MED-LINKET CORP
  • 16.2.7 SORIMEX
  • 16.2.8 NUOVA
  • 16.2.9 LUMED SRL
  • 16.2.10 SHENZHEN UPNMED EQUIPMENT CO., LTD.
  • 16.2.11 SINO-K MEDICAL
  • 16.2.12 IVY BIOMEDICAL SYSTEMS, INC
  • 16.2.13 ACCUSYNC MEDICAL RESEARCH CORPORATION
  • 16.2.14 BIOMETRIC CABLES

17 APPENDIX

• 17.1 DISCUSSION GUIDE
• 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 17.3 CUSTOMIZATION OPTIONS
  • 17.3.1 COMPANY INFORMATION
  • 17.3.2 GEOGRAPHIC ANALYSIS
  • 17.3.3 REGIONAL/COUNTRY-LEVEL MARKET SHARE ANALYSIS
  • 17.3.4 COUNTRY-LEVEL VOLUME ANALYSIS
  • 17.3.5 ANY CONSULTS/CUSTOM REQUIREMENTS AS PER CLIENT REQUEST
• 17.4 RELATED REPORTS
• 17.5 AUTHOR DETAILS